PMID- 34987297
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220429
IS  - 1179-173X (Print)
IS  - 1179-173X (Electronic)
IS  - 1179-173X (Linking)
VI  - 14
DP  - 2021
TI  - Evaluating the impact of culturally specific patient-centric behavioral 
      intervention package versus usual care for tobacco cessation among patients 
      attending noncommunicable disease clinics in North India: A single-blind trial 
      pilot study protocol.
PG  - 1179173X211056622
LID - 10.1177/1179173X211056622 [doi]
LID - 1179173X211056622
AB  - BACKGROUND: In a low and middle-income country (LMIC) like India, 
      non-communicable diseases (NCDs) contribute a major proportion (61.8%) of all 
      causes of death. Out of this, 48% of cardiovascular diseases , 23% of Chronic 
      Respiratory Diseases , and 10% of Cancer deaths are attributable to tobacco use. 
      Tobacco use is a major risk factor for NCDs and thus, the tobacco cessation 
      approach is a high priority intervention to combat complications and death among 
      NCD patients. While several interventions are available for tobacco cessation, in 
      resource constraint countries like India, the effectiveness of low-cost, 
      culturally specific patient-centric tobacco cessation behavioral intervention 
      holds a potential that needs to be evaluated. A newly developed evidence-based 
      tobacco cessation intervention package will be compared with the existing/usual 
      care provided under the National Programme for Prevention and Control of Cancers, 
      Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) at NCD clinics. METHODS 
      AND DESIGN: 2 arm, parallel-group randomized controlled trial. PARTICIPANTS: 
      Patients aged >/=30 years suffering from NCD, currently using tobacco, and 
      attending NCD clinics in 2 districts of Punjab, India. SAMPLE SIZE: A total of 
      200 participants meeting the selection criteria will be recruited. They will be 
      allocated either to the intervention arm or control (usual care) arm (100 each) 
      using block randomization. INTERVENTION: For the participants, there will be 4 
      face-to-face disease-specific cessation counseling sessions, disease-specific 
      pamphlets, short text messages in vernacular language, that is, Punjabi. 
      Follow-ups will be done at the third, sixth, ninth, and 12th months. PRIMARY 
      OUTCOME: Seven-day abstinence, biochemically verified by plasma cotinine levels. 
      SECONDARY OUTCOME: Quit attempts, number of sticks/number of times of smokeless 
      tobacco usage in a day, and stage of behavior change in tobacco users. 
      DISCUSSION: This multicomponent culturally specific-patient-centric behavioral 
      intervention package for tobacco cessation at NCD clinic settings focusing on the 
      individual, family, and social environment could increase the outreach of 
      cessation services using existing resources, thereby strengthening health systems 
      and enhancing the quality of life of NCD patients. TRIAL REGISTRATION: The 
      protocol for the study has been registered with the Clinical Trials Registry in 
      India under the registration number CTRI/2018/01/011643.
CI  - (c) The Author(s) 2021.
FAU - Bhatt, Garima
AU  - Bhatt G
AUID- ORCID: 0000-0002-5258-7339
AD  - Department of Community Medicine and School of Public Health, Post Graduate 
      Institute of Medical Education and Research (PGIMER), Chandigarh, India. 
      RINGGOLD: 463462
FAU - Goel, Sonu
AU  - Goel S
AUID- ORCID: 0000-0001-5231-7083
AD  - Department of Community Medicine and School of Public Health, Post Graduate 
      Institute of Medical Education and Research (PGIMER), Chandigarh, India. 
      RINGGOLD: 463462
FAU - Gupta, Rakesh
AU  - Gupta R
AD  - Honorary Consultant, Tobacco Cessation, Department of Deaddiction, Santokba 
      Durlabhji Memorial Hospital and Medical Research Institution, Jaipur, India. 
      RINGGOLD: 29783
FAU - Grover, Sandeep
AU  - Grover S
AUID- ORCID: 0000-0003-0365-7086
AD  - Department of Psychiatry, Post Graduate Institute of Medical Education and 
      Research (PGIMER), Chandigarh, India. RINGGOLD: 29751
FAU - Medhi, Bikash
AU  - Medhi B
AD  - Department of Pharmacology, Post Graduate Institute of Medical Education and 
      Research (PGIMER), Chandigarh, India. RINGGOLD: 29751
LA  - eng
PT  - Journal Article
DEP - 20211223
PL  - United States
TA  - Tob Use Insights
JT  - Tobacco use insights
JID - 101608659
PMC - PMC8721367
OTO - NOTNLM
OT  - cessation
OT  - cotinine
OT  - high-pressure liquid chromatography
OT  - noncommunicable disease clinic
OT  - randomized controlled trial
EDAT- 2022/01/07 06:00
MHDA- 2022/01/07 06:01
PMCR- 2021/12/23
CRDT- 2022/01/06 05:51
PHST- 2020/12/20 00:00 [received]
PHST- 2020/10/08 00:00 [accepted]
PHST- 2022/01/06 05:51 [entrez]
PHST- 2022/01/07 06:00 [pubmed]
PHST- 2022/01/07 06:01 [medline]
PHST- 2021/12/23 00:00 [pmc-release]
AID - 10.1177_1179173X211056622 [pii]
AID - 10.1177/1179173X211056622 [doi]
PST - epublish
SO  - Tob Use Insights. 2021 Dec 23;14:1179173X211056622. doi: 
      10.1177/1179173X211056622. eCollection 2021.